Biomarin Pharmaceutical (BMRN) Land & Improvements (2010 - 2013)

Biomarin Pharmaceutical (BMRN) has 4 years of Land & Improvements data on file, last reported at $74.9 million in Q4 2013.

• Quarterly Land & Improvements rose 33.81% year-over-year to $74.9 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $74.9 million (up 33.81% YoY) and the FY2013 annual result came in at $74.9 million, up 33.81% from the prior year.
• Land & Improvements grew to $74.9 million in Q4 2013, from $63.2 million in the prior quarter.
• In the past five years, Land & Improvements ranged from a high of $74.9 million in Q4 2013 to a low of $10.1 million in Q2 2012.
• A 4-year average of $51.0 million and a median of $54.5 million in 2012 frame the typical range for Land & Improvements.
• Annual changes were most pronounced in 2012 — Land & Improvements increased 15.33% — and 2013, when it surged 501.02%.
• Tracing BMRN's Land & Improvements over 4 years: stood at $37.7 million in 2010, then grew by 28.99% to $48.6 million in 2011, then increased by 15.33% to $56.0 million in 2012, then soared by 33.81% to $74.9 million in 2013.
• The last three Land & Improvements figures came in at $74.9 million (Q4 2013), $63.2 million (Q3 2013), and $60.4 million (Q2 2013), per Business Quant data.